Detalhe da pesquisa
1.
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
Cell
; 184(15): 3936-3948.e10, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192529
2.
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.
Immunity
; 57(3): 587-599.e4, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395697
3.
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
Nature
; 602(7898): 682-688, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016197
4.
Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections.
J Infect Dis
; 228(5): 564-575, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104046
5.
Development of a novel serological assay for the detection of mpox infection in vaccinated populations.
J Med Virol
; 95(10): e29134, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805977
6.
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
N Engl J Med
; 384(14): 1372-1374, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691060
7.
The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera.
mBio
; 15(1): e0225023, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112467
8.
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.
mBio
; : e0228023, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092666
9.
Development of a Novel Serological Assay for the Detection of Mpox Infection in Vaccinated Populations.
medRxiv
; 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162953
10.
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.
J Clin Invest
; 133(8)2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862518
11.
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.
Sci Transl Med
; 15(683): eabo2847, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791207
12.
Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma.
EBioMedicine
; 98: 104886, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37995467
13.
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants.
Nat Commun
; 14(1): 3235, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270625
14.
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
Nat Commun
; 13(1): 5135, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050304
15.
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.
mBio
; 13(5): e0178422, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997286
16.
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations.
Vaccine
; 40(42): 6114-6124, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115801
17.
Accelerometry Data Delineate Phases of Recovery and Supplement Patient-Reported Outcome Measures Following Lumbar Laminectomy.
World Neurosurg
; 160: e608-e615, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104658
18.
PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.
mSphere
; 7(3): e0017922, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586986
19.
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.
EBioMedicine
; 73: 103626, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688034
20.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
medRxiv
; 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758878